Aptamer-grafted, cell membrane-coated dendrimer loaded with doxorubicin as a targeted nanosystem against epithelial cellular adhesion molecule (EpCAM) for triple negative breast cancer therapy-Reference-Cited by-同舟云学术

Aptamer-grafted, cell membrane-coated dendrimer loaded with doxorubicin as a targeted nanosystem against epithelial cellular adhesion molecule (EpCAM) for triple negative breast cancer therapy

Published:2023-09 Issue: Volume:86 Page:104745
ISSN:1773-2247
Container-title:Journal of Drug Delivery Science and Technology
language:en
Short-container-title:Journal of Drug Delivery Science and Technology

Author:

Sheikh Afsana,Abourehab Mohammed A.S.^ORCID,Tulbah Alaa S.^ORCID,Kesharwani Prashant^ORCID

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference67 articles.

1. Triple-negative breast cancer therapy: current and future perspectives;Won;Int. J. Oncol.,2020

2. Nanoparticles-based drug delivery and gene therapy for breast cancer: recent advancements and future challenges;Mirza;Semin. Cancer Biol.,2021

3. Triple-negative breast cancer molecular subtyping and treatment progress;Yin;Breast Cancer Res.,2020

4. New opportunities for RGD-engineered metal nanoparticles in cancer;Qin;Mol. Cancer,2023

5. Advancements in nanoparticle-based treatment approaches for skin cancer therapy;Zeng;Mol. Cancer,2023

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implications of nanotherapeutic advancements to leverage multi-drug resistant breast cancer: The state-of-the-art review;Journal of Drug Delivery Science and Technology;2024-10

2. Recent Advances in Immunotherapy and Targeted Therapy of Triple Negative Breast Cancer;Current Pharmaceutical Biotechnology;2024-07-31

3. Molecular Mechanism of Novel PAMAM Dendrimer Decorated Tectona grandis and Lactobacillus plantarum Nanoparticles on Autophagy-Induced Apoptosis in TNBC Cells;BioNanoScience;2024-07-17

4. Multicenter proteome-wide Mendelian randomization study identifies causal plasma proteins in melanoma and non-melanoma skin cancers;Communications Biology;2024-07-13

5. A comprehensive review on doxorubicin: mechanisms, toxicity, clinical trials, combination therapies and nanoformulations in breast cancer;Drug Delivery and Translational Research;2024-06-17